Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cells

被引：0
作者：
T Numbenjapon
L M Serrano
H Singh
C M Kowolik
S Olivares
N Gonzalez
W C Chang
S J Forman
M C Jensen
L J N Cooper
机构：
[1] Beckman Research Institute and City of Hope National Medical Center,Division of Molecular Medicine
[2] Beckman Research Institute and City of Hope National Medical Center,Division of Cancer Immunotherapeutics and Tumor Immunology
[3] Beckman Research Institute and City of Hope National Medical Center,Division of Hematology and Hematopoietic Cell Transplantation
[4] Beckman Research Institute and City of Hope National Medical Center,Division of Pediatric Hematology/Oncology
[5] Phramongkutklao Royal Thai Army,Division of Hematology, Department of Medicine
[6] Hospital and College of Medicine,Division of Pediatrics
[7] Children's Cancer Hospital,undefined
[8] University of Texas MD Anderson Cancer Center,undefined
来源：
Leukemia | 2006年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1889 / 1892
页数：3
相关论文
共 50 条
[21]   Activation and expansion of human T cells using artificial antigen-presenting cell scaffolds [J].
David K. Y. Zhang ;
Alexander S. Cheung ;
David J. Mooney .
Nature Protocols, 2020, 15 :773-798
[22]   Fully human CD19-specific chimeric antigen receptors for T-cell therapy [J].
Sommermeyer, D. ;
Hill, T. ;
Shamah, S. M. ;
Salter, A. I. ;
Chen, Y. ;
Mohler, K. M. ;
Riddell, S. R. .
LEUKEMIA, 2017, 31 (10) :2191-2199
[23]   Adoptive cellular immunotherapy with CD19-specific T cells [J].
Rössig, C ;
Pscherer, S ;
Landmeier, S ;
Altvater, B ;
Jürgens, H ;
Vormoor, J .
KLINISCHE PADIATRIE, 2005, 217 (06) :351-356
[24]   Fully human CD19-specific chimeric antigen receptors for T-cell therapy [J].
D Sommermeyer ;
T Hill ;
S M Shamah ;
A I Salter ;
Y Chen ;
K M Mohler ;
S R Riddell .
Leukemia, 2017, 31 :2191-2199
[25]   Activation requirements of circulating antigen-specific human CD8+ memory T cells probed with insect cell-based artificial antigen-presenting cells [J].
Guelly, C ;
Küpcü, Z ;
Zalusky, D ;
Karner, M ;
Zehetner, M ;
Schweighoffer, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (01) :182-192
[26]   Quantitative single-cell functional characterization of CD19-specific CAR plus T Cells for irnmunotherapy [J].
Varadarajan, Navin ;
Liadi, Ivan ;
Romain, Gabrielle ;
Singh, Harjeet ;
Cooper, Laurence J. N. .
CANCER RESEARCH, 2013, 73 (08)
[27]   RESPONSE OF NAIVE ANTIGEN-SPECIFIC CD4+ T-CELLS INVITRO - CHARACTERISTICS AND ANTIGEN-PRESENTING CELL REQUIREMENTS [J].
CROFT, M ;
DUNCAN, DD ;
SWAIN, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1431-1437
[28]   The role of antigen-presenting cells in the regulation of allergen-specific T cell responses [J].
Kapsenberg, ML ;
Hilkens, CMU ;
Wierenga, EA ;
Kalinski, P .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (06) :607-613
[29]   Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posarcansplantation adoptive immunotherapy [J].
Serrano, LM ;
Pfeiffer, T ;
Olivares, S ;
Numbenjapon, T ;
Bennitt, J ;
Kim, D ;
Smith, D ;
McNamara, G ;
Al-Kadhimi, Z ;
Rosenthal, J ;
Forman, SJ ;
Jensen, MC ;
Cooper, LJN .
BLOOD, 2006, 107 (07) :2643-2652
[30]   Artificial Biosystem for Modulation of Interactions between Antigen-Presenting Cells and T Cells [J].
Alatoom, Aseel ;
Sapudom, Jiranuwat ;
Soni, Priya ;
Mohamed, Walaa Kamal E. ;
Garcia-Sabate, Anna ;
Teo, Jeremy .
ADVANCED BIOSYSTEMS, 2020, 4 (07)
12345